These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 487868)

  • 1. Fibrinogen degradation products in acute myocardial infarction.
    Buch J
    Dan Med Bull; 1979 Jul; 26(4):206-8. PubMed ID: 487868
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunoenzyme determination of fibrin-fibrinogen degradation product levels in acute myocardial infarct patients].
    Grinshteĭn IA; Ignashenkova GV; Kitaev MI
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):18-21. PubMed ID: 3300697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fibrinogen and fibrin degradation products in serum and their prognostic significance in acute myocardial infarct].
    Krug H; Gryglik J; Jasiński K; Gluszek J
    Kardiol Pol; 1977; 20(1):9-14. PubMed ID: 846061
    [No Abstract]   [Full Text] [Related]  

  • 4. [The behaviour of fibrinogen and fibrinogen degradation products in myocardial infarction. Justification of a prognostic index (author's transl)].
    Abizanda Campos R; Forner Sánchez N; Carrió Soldevilla M; Florit Serra J
    Med Clin (Barc); 1979 Dec; 73(10):429-34. PubMed ID: 529865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrin degradation products in acute myocardial infarction.
    Arya TV; Goel VK; Mehrotra TN; Singh VS; Rajvanshi S; Raka MS
    J Assoc Physicians India; 1983 Nov; 31(11):691-2. PubMed ID: 6671945
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fibrin/fibrinogen degradation products in the diagnosis of pulmonary thromboembolism].
    Ena IaM; Drannik GN; Konopleva LF
    Ter Arkh; 1985; 57(4):143-6. PubMed ID: 3892752
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fibrin-fibrinogen degradation products (F.D.P.) in thromboembolism and other diseases].
    Jones DR; Webber A; Prescott RJ; Allan NC; Ruckley CV
    Vasa; 1976; 5(4):332-7. PubMed ID: 1007541
    [No Abstract]   [Full Text] [Related]  

  • 8. [The content of fibronectin, fibrinogen, its degradation products and myoglobin in patients with ischemic heart disease].
    Malaia LT; Volkov VI; Topchiĭ II; Dykun IaV; Shuliak LN
    Ter Arkh; 1990; 62(11):87-90. PubMed ID: 2095000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early diagnosis of myocardial infarct. The determination of myoglobin and fibrin-degradation products in the blood serum].
    Orbetsov M; Milanov S; Stankusheva G; Sheĭretova E; Atanasov I
    Vutr Boles; 1986; 25(2):39-44. PubMed ID: 3716376
    [No Abstract]   [Full Text] [Related]  

  • 10. A study of soluble fibrin monomer complexes (SFMC) and plasma fibrinogen in acute myocardial infarction.
    Jain SM; Trivedi S
    Indian J Chest Dis Allied Sci; 1984; 26(2):98-103. PubMed ID: 6530267
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fibrinogen and fibrin degradation products (FDP) in serum of patients with acute myocardial infarct and with imminent infarct].
    Kedra M; Kutarski A; Dmoxzyńska A
    Pol Tyg Lek; 1975 Sep; 30(37):1517-21. PubMed ID: 1161615
    [No Abstract]   [Full Text] [Related]  

  • 12. [2 simple methods of detecting fibrin degradation products in blood].
    Gabitov SZ; Voronina IE; Litvinov RI
    Lab Delo; 1982; (6):34-6. PubMed ID: 6180231
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
    Mombelli G; Monotti R; Haeberli A; Straub PW
    Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipids and fibrin-fibrinogen degradation products levels in the serum in acute myocardial infarct].
    Kutarski A; Dmoszyńska A; Rymar B; Staśkiewicz J
    Pol Tyg Lek; 1976 Apr; 31(14):565-8. PubMed ID: 1272944
    [No Abstract]   [Full Text] [Related]  

  • 15. [Significance of plasma-protein paracoagulation test in the diagnosis of thromboembolic the disease].
    Braun P; Meskó E; Gedeon A
    Z Gesamte Inn Med; 1976 Sep; 31(18):758-9. PubMed ID: 1007337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolytic activity in coronary heart disease.
    Yao SK; Chen ZJ; Tao SQ
    Chin Med J (Engl); 1989 Sep; 102(9):660-3. PubMed ID: 2517077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemorrhage vs rethrombosis after thrombolysis for acute myocardial infarction.
    Timmis GC; Mammen EF; Ramos RG; Gordon S; Gangadharan V; Hauser AM; Westveer DC; Stewart JR
    Arch Intern Med; 1986 Apr; 146(4):667-72. PubMed ID: 3963947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The significance of changes in fibrinogen levels during thrombolytic therapy in myocardial infarct].
    Malý J; Pecka M; Pidrman V; Hamet A; Gregor J; Vodicka L; Siroký O; Tichý M
    Vnitr Lek; 1991 Mar; 37(3):229-37. PubMed ID: 2031311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical value of studying fibrinogen degradation products in patients with ischemic heart disease].
    Ikonnikova EI; Katkova NB; Filippova SB
    Klin Med (Mosk); 1989 May; 67(5):35-6. PubMed ID: 2770207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of fibrinogen and fibrin degradation products (DFP) in the acute stage of myocardial infarction].
    Baele G; Mussche M; Vermeire P; Pannier R
    Arch Mal Coeur Vaiss; 1973 Apr; 66(4):427-9. PubMed ID: 4198846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.